Cargando…

Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis

Detalles Bibliográficos
Autores principales: Ye, Ting-Hong, Yang, Fang-Fang, Zhu, Yong-Xia, Li, Ya-Li, Lei, Qian, Song, Xue-Jiao, Xia, Yong, Xiong, Ying, Zhang, Li-Dan, Wang, Ning-Yu, Zhao, Li-Feng, Gou, Hong-Feng, Xie, Yong-Mei, Yang, Sheng-Yong, Yu, Luo-Ting, Yang, Li, Wei, Yu-Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763466/
https://www.ncbi.nlm.nih.gov/pubmed/31558703
http://dx.doi.org/10.1038/s41419-019-1955-9
_version_ 1783454203140636672
author Ye, Ting-Hong
Yang, Fang-Fang
Zhu, Yong-Xia
Li, Ya-Li
Lei, Qian
Song, Xue-Jiao
Xia, Yong
Xiong, Ying
Zhang, Li-Dan
Wang, Ning-Yu
Zhao, Li-Feng
Gou, Hong-Feng
Xie, Yong-Mei
Yang, Sheng-Yong
Yu, Luo-Ting
Yang, Li
Wei, Yu-Quan
author_facet Ye, Ting-Hong
Yang, Fang-Fang
Zhu, Yong-Xia
Li, Ya-Li
Lei, Qian
Song, Xue-Jiao
Xia, Yong
Xiong, Ying
Zhang, Li-Dan
Wang, Ning-Yu
Zhao, Li-Feng
Gou, Hong-Feng
Xie, Yong-Mei
Yang, Sheng-Yong
Yu, Luo-Ting
Yang, Li
Wei, Yu-Quan
author_sort Ye, Ting-Hong
collection PubMed
description
format Online
Article
Text
id pubmed-6763466
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67634662019-09-27 Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis Ye, Ting-Hong Yang, Fang-Fang Zhu, Yong-Xia Li, Ya-Li Lei, Qian Song, Xue-Jiao Xia, Yong Xiong, Ying Zhang, Li-Dan Wang, Ning-Yu Zhao, Li-Feng Gou, Hong-Feng Xie, Yong-Mei Yang, Sheng-Yong Yu, Luo-Ting Yang, Li Wei, Yu-Quan Cell Death Dis Correction Nature Publishing Group UK 2019-09-26 /pmc/articles/PMC6763466/ /pubmed/31558703 http://dx.doi.org/10.1038/s41419-019-1955-9 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correction
Ye, Ting-Hong
Yang, Fang-Fang
Zhu, Yong-Xia
Li, Ya-Li
Lei, Qian
Song, Xue-Jiao
Xia, Yong
Xiong, Ying
Zhang, Li-Dan
Wang, Ning-Yu
Zhao, Li-Feng
Gou, Hong-Feng
Xie, Yong-Mei
Yang, Sheng-Yong
Yu, Luo-Ting
Yang, Li
Wei, Yu-Quan
Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
title Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
title_full Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
title_fullStr Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
title_full_unstemmed Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
title_short Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
title_sort correction: inhibition of stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763466/
https://www.ncbi.nlm.nih.gov/pubmed/31558703
http://dx.doi.org/10.1038/s41419-019-1955-9
work_keys_str_mv AT yetinghong correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT yangfangfang correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT zhuyongxia correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT liyali correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT leiqian correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT songxuejiao correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT xiayong correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT xiongying correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT zhanglidan correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT wangningyu correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT zhaolifeng correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT gouhongfeng correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT xieyongmei correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT yangshengyong correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT yuluoting correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT yangli correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis
AT weiyuquan correctioninhibitionofstat3signalingpathwaybynifuroxazideimprovesantitumorimmunityandimpairscolorectalcarcinomametastasis